Published in Menopause on October 01, 2015
The Association between Body Mass Index and Hot Flash in Midlife Women: A Meta-analysis. J Menopausal Med (2016) 0.80
Phthalate metabolite levels and menopausal hot flashes in midlife women. Reprod Toxicol (2016) 0.76
Impact of CYP19A1 and ESR1 variants on early-onset side effects during combined endocrine therapy in the TEXT trial. Breast Cancer Res (2016) 0.75
Anxiogenic CO2 stimulus elicits exacerbated hot flash-like responses in a rat menopause model and hot flashes in postmenopausal women. Menopause (2016) 0.75
Age at menarche, androgen concentrations, and midlife obesity: findings from the Midlife Women's Health Study. Menopause (2016) 0.75
Longitudinal analysis of the association between vasomotor symptoms and race/ethnicity across the menopausal transition: study of women's health across the nation. Am J Public Health (2006) 4.51
Relation of demographic and lifestyle factors to symptoms in a multi-racial/ethnic population of women 40-55 years of age. Am J Epidemiol (2000) 3.51
Symptoms associated with menopausal transition and reproductive hormones in midlife women. Obstet Gynecol (2007) 2.65
Abdominal adiposity and hot flashes among midlife women. Menopause (2008) 2.65
Cigarette smoking and urinary estrogens. N Engl J Med (1982) 2.55
Hot flashes and subclinical cardiovascular disease: findings from the Study of Women's Health Across the Nation Heart Study. Circulation (2008) 2.33
The menopausal hot flush--anything new? Maturitas (2008) 1.98
Risk of long-term hot flashes after natural menopause: evidence from the Penn Ovarian Aging Study cohort. Menopause (2014) 1.75
Reduced thermoregulatory null zone in postmenopausal women with hot flashes. Am J Obstet Gynecol (1999) 1.69
Smoking, body mass, and hot flashes in midlife women. Obstet Gynecol (2003) 1.63
Psychosocial and socioeconomic burden of vasomotor symptoms in menopause: a comprehensive review. Health Qual Life Outcomes (2005) 1.53
Comparison of the antioxidant effects of equine estrogens, red wine components, vitamin E, and probucol on low-density lipoprotein oxidation in postmenopausal women. Menopause (2001) 1.53
Prevalence of hot flushes and night sweats around the world: a systematic review. Climacteric (2007) 1.50
Oral micronized progesterone for vasomotor symptoms--a placebo-controlled randomized trial in healthy postmenopausal women. Menopause (2012) 1.44
Duration of menopausal hot flushes and associated risk factors. Obstet Gynecol (2011) 1.31
Prevalence of menopause symptoms and their association with lifestyle among Finnish middle-aged women. Maturitas (2010) 1.26
New findings from non-linear longitudinal modelling of menopausal hormone changes. Hum Reprod Update (2007) 1.25
Alcohol and endogenous sex steroid levels in postmenopausal women: a cross-sectional study. J Clin Endocrinol Metab (2004) 1.25
Modeling women's health during the menopausal transition: a longitudinal analysis. Menopause (2007) 1.24
Body mass, estrogen levels, and hot flashes in midlife women. Am J Obstet Gynecol (2005) 1.22
Impact of stress on objectively recorded menopausal hot flushes and on flush report bias. Health Psychol (1990) 1.19
Menopause-related symptoms: what are the background factors? A prospective population-based cohort study of Swedish women (The Women's Health in Lund Area study). Am J Obstet Gynecol (2003) 1.17
Cigarette smoking, estrogen levels, and hot flashes in midlife women. Maturitas (2006) 1.16
The role of serotonin in hot flushes. Maturitas (2000) 1.15
Differential association of modifiable health behaviors with hot flashes in perimenopausal and postmenopausal women. J Gen Intern Med (2004) 1.13
Risk factors for onset of menopausal symptoms: results from a large cohort study. Maturitas (2008) 1.11
Risk factors for menopausal hot flashes. Obstet Gynecol (1994) 1.10
Predictors of menopausal hot flashes. J Womens Health (1998) 1.10
The effects of moderate alcohol consumption on female hormone levels and reproductive function. Alcohol Alcohol (2000) 1.09
A longitudinal study of the predictors of prevalence and severity of symptoms commonly associated with menopause. Menopause (2005) 1.08
Soy product intake and hot flashes in Japanese women: results from a community-based prospective study. Am J Epidemiol (2001) 1.04
Genetic polymorphisms, hormone levels, and hot flashes in midlife women. Maturitas (2006) 1.02
Health-related quality of life of women with menopausal hot flushes and night sweats. Climacteric (2012) 1.01
Relation of body mass and sex steroid hormone levels to hot flushes in a sample of mid-life women. Climacteric (2007) 0.99
Hormone replacement therapy for oxidative stress in postmenopausal women with hot flushes. Obstet Gynecol (2000) 0.95
Change in body mass index, weight, and hot flashes: a longitudinal analysis from the midlife women's health study. J Womens Health (Larchmt) (2013) 0.95
Cigarette smoking, androgen levels, and hot flushes in midlife women. Obstet Gynecol (2008) 0.93
Hormone replacement therapy and lens opacities: the Salisbury Eye Evaluation project. Arch Ophthalmol (2001) 0.92
Joint effects of smoking and gene variants involved in sex steroid metabolism on hot flashes in late reproductive-age women. J Clin Endocrinol Metab (2012) 0.88
Hot flushes, common symptoms, and social relations among middle-aged nonmenopausal French women in the GAZEL cohort. Menopause (2006) 0.88
Self-reported anxiety, depressive, and vasomotor symptoms: a study of perimenopausal women presenting to a specialized midlife assessment center. Menopause (2010) 0.87
Determinants of hot flashes and night sweats. Ann Hum Biol (2006) 0.87
Factors that may influence the experience of hot flushes by healthy middle-aged women. J Womens Health (Larchmt) (2010) 0.83
The impact of menopausal symptoms on quality of life, productivity, and economic outcomes. J Womens Health (Larchmt) (2013) 0.83
Reproductive history and hot flashes in perimenopausal women. J Womens Health (Larchmt) (2012) 0.82
Risk factors for night sweats and hot flushes in midlife: results from a prospective cohort study. Menopause (2013) 0.82
The relationship of menopausal hot flushes to medical and reproductive experience. J Gerontol (1981) 0.82
The association between vasomotor symptoms and depression during perimenopause: a systematic review. Maturitas (2013) 0.79
The effectiveness of sublingual and topical compounded bioidentical hormone replacement therapy in postmenopausal women: an observational cohort study. Int J Pharm Compd (2014) 0.78
Current alcohol use, hormone levels, and hot flashes in midlife women. Fertil Steril (2007) 0.78
Factors associated with reporting classic menopausal symptoms differ. Climacteric (2012) 0.78
Progesterone for hot flush and night sweat treatment--effectiveness for severe vasomotor symptoms and lack of withdrawal rebound. Gynecol Endocrinol (2012) 0.77
The influence of premenopausal hormones on severity of climacteric symptoms and use of HRT. Climacteric (2006) 0.77
Long-term corticosteroid replacement and bone mineral density in adult women with classical congenital adrenal hyperplasia. J Clin Endocrinol Metab (2005) 1.63
Smoking, body mass, and hot flashes in midlife women. Obstet Gynecol (2003) 1.63
Bisphenol a and reproductive health: update of experimental and human evidence, 2007-2013. Environ Health Perspect (2014) 1.61
BRCA2 deficiency in mice leads to meiotic impairment and infertility. Development (2003) 1.55
Body mass and stage of breast cancer at diagnosis. Int J Cancer (2002) 1.54
Urinary bisphenol A concentrations and early reproductive health outcomes among women undergoing IVF. Hum Reprod (2012) 1.48
Deregulated estrogen receptor alpha expression in mammary epithelial cells of transgenic mice results in the development of ductal carcinoma in situ. Cancer Res (2005) 1.46
Methoxychlor inhibits growth and induces atresia of antral follicles through an oxidative stress pathway. Toxicol Sci (2006) 1.40
Urinary bisphenol A concentrations and implantation failure among women undergoing in vitro fertilization. Environ Health Perspect (2012) 1.34
Ovarian abnormalities in a mouse model of fragile X primary ovarian insufficiency. J Histochem Cytochem (2012) 1.29
Methoxychlor metabolites may cause ovarian toxicity through estrogen-regulated pathways. Toxicol Sci (2006) 1.28
Bisphenol A impairs follicle growth, inhibits steroidogenesis, and downregulates rate-limiting enzymes in the estradiol biosynthesis pathway. Toxicol Sci (2010) 1.26
The role of the aryl hydrocarbon receptor in the female reproductive system. Biochem Pharmacol (2008) 1.25
Cytochrome gene polymorphisms, serum estrogens, and hot flushes in midlife women. Obstet Gynecol (2005) 1.25
Methoxychlor directly affects ovarian antral follicle growth and atresia through Bcl-2- and Bax-mediated pathways. Toxicol Sci (2005) 1.24
Body mass, estrogen levels, and hot flashes in midlife women. Am J Obstet Gynecol (2005) 1.22
Activation of mitogen-activated protein kinases and AP-1 transcription factor in ovotoxicity induced by 4-vinylcyclohexene diepoxide in rats. Biol Reprod (2002) 1.17
Cigarette smoking, estrogen levels, and hot flashes in midlife women. Maturitas (2006) 1.16
Treatment of premenstrual dysphoric disorder with a new drospirenone-containing oral contraceptive formulation. Contraception (2005) 1.12
Risk factors for hot flashes in midlife women. J Womens Health (Larchmt) (2003) 1.12
Acute and chronic effects of oral genistein administration in neonatal mice. Biol Reprod (2010) 1.12
Can obesity explain the racial difference in stage of breast cancer at diagnosis between black and white women? J Womens Health Gend Based Med (2002) 1.11
Differences between rats and mice in the involvement of the aryl hydrocarbon receptor in 4-vinylcyclohexene diepoxide-induced ovarian follicle loss. Toxicol Appl Pharmacol (2005) 1.10
Di (2-ethylhexyl) phthalate inhibits growth of mouse ovarian antral follicles through an oxidative stress pathway. Toxicol Appl Pharmacol (2011) 1.09
Association between race and hot flashes in midlife women. Maturitas (2006) 1.08
Phase II study of G3139, a Bcl-2 antisense oligonucleotide, in combination with dexamethasone and thalidomide in relapsed multiple myeloma patients. J Clin Oncol (2005) 1.08
Physical activity and risk of hot flashes among women in midlife. J Womens Health (Larchmt) (2007) 1.07
Ovarian follicle development requires Smad3. Mol Endocrinol (2004) 1.06
Depressive symptoms and self-reported fast-food intake in midlife women. Prev Med (2011) 1.06
Di-(2-ethylhexyl) phthalate and mono-(2-ethylhexyl) phthalate inhibit growth and reduce estradiol levels of antral follicles in vitro. Toxicol Appl Pharmacol (2009) 1.05
Age of menopause and menopausal symptoms in HIV-infected women. AIDS Patient Care STDS (2005) 1.04
Type of menopause, patterns of hormone therapy use, and hot flashes. Fertil Steril (2006) 1.04
Introduction of estrogen receptor-alpha into the tTA/TAg conditional mouse model precipitates the development of estrogen-responsive mammary adenocarcinoma. Am J Pathol (2003) 1.03
Relations among menopausal symptoms, sleep disturbance and depressive symptoms in midlife. Maturitas (2009) 1.02
Genetic polymorphisms, hormone levels, and hot flashes in midlife women. Maturitas (2006) 1.02
Endocrine-disrupting chemicals in ovarian function: effects on steroidogenesis, metabolism and nuclear receptor signaling. Reproduction (2011) 1.01
Methoxychlor-induced atresia in the mouse involves Bcl-2 family members, but not gonadotropins or estradiol. Biol Reprod (2004) 1.00
Bisphenol A inhibits follicle growth and induces atresia in cultured mouse antral follicles independently of the genomic estrogenic pathway. Biol Reprod (2012) 0.99
In utero effects of chemicals on reproductive tissues in females. Toxicol Appl Pharmacol (2004) 0.98
Correlates of depressive symptoms among women undergoing the menopausal transition. J Psychosom Res (2007) 0.98
The aryl hydrocarbon receptor affects mouse ovarian follicle growth via mechanisms involving estradiol regulation and responsiveness. Biol Reprod (2007) 0.98
Aryl hydrocarbon receptor regulates growth, but not atresia, of mouse preantral and antral follicles. Biol Reprod (2002) 0.95
Polymorphisms in cytochrome P4503A5 (CYP3A5) may be associated with race and tumor characteristics, but not metabolism and side effects of tamoxifen in breast cancer patients. Cancer Lett (2005) 0.95
NTP-CERHR expert panel report on the reproductive and developmental toxicity of genistein. Birth Defects Res B Dev Reprod Toxicol (2006) 0.95
Change in body mass index, weight, and hot flashes: a longitudinal analysis from the midlife women's health study. J Womens Health (Larchmt) (2013) 0.95
Current alcohol use is associated with a reduced risk of hot flashes in midlife women. Alcohol Alcohol (2005) 0.94
Autophagy is a cell survival program for female germ cells in the murine ovary. Reproduction (2011) 0.94
BAX regulates follicular endowment in mice. Reproduction (2007) 0.94
Mono-(2-ethylhexyl) phthalate induces oxidative stress and inhibits growth of mouse ovarian antral follicles. Biol Reprod (2012) 0.93
Cigarette smoking, androgen levels, and hot flushes in midlife women. Obstet Gynecol (2008) 0.93
Impact of environmental factors and poverty on pregnancy outcomes. Clin Obstet Gynecol (2008) 0.92
Di-n-butyl phthalate disrupts the expression of genes involved in cell cycle and apoptotic pathways in mouse ovarian antral follicles. Biol Reprod (2013) 0.91
The aryl hydrocarbon receptor is required for normal gonadotropin responsiveness in the mouse ovary. Toxicol Appl Pharmacol (2007) 0.91
Methoxychlor inhibits brain mitochondrial respiration and increases hydrogen peroxide production and CREB phosphorylation. Toxicol Sci (2005) 0.91
Effects of ERalpha overexpression on female reproduction in mice. Reprod Toxicol (2006) 0.91
NTP-CERHR expert panel report on the reproductive and developmental toxicity of soy formula. Birth Defects Res B Dev Reprod Toxicol (2006) 0.90
Conditional over-expression of estrogen receptor alpha in a transgenic mouse model. Transgenic Res (2002) 0.90
Association of tamoxifen (TAM) and TAM metabolite concentrations with self-reported side effects of TAM in women with breast cancer. Breast Cancer Res Treat (2004) 0.89
Serum leptin levels, hormone levels, and hot flashes in midlife women. Fertil Steril (2009) 0.89
The association between menopausal symptoms and quality of life in midlife women. Fertil Steril (2006) 0.88
Prenatal exposure to low doses of bisphenol A increases pituitary proliferation and gonadotroph number in female mice offspring at birth. Biol Reprod (2012) 0.88
Mono-hydroxy methoxychlor alters levels of key sex steroids and steroidogenic enzymes in cultured mouse antral follicles. Toxicol Appl Pharmacol (2010) 0.88
Methoxychlor and estradiol induce oxidative stress DNA damage in the mouse ovarian surface epithelium. Toxicol Sci (2008) 0.88
Increased sensitivity of estrogen receptor alpha overexpressing antral follicles to methoxychlor and its metabolites. Toxicol Sci (2011) 0.87
Methoxychlor induces proliferation of the mouse ovarian surface epithelium. Toxicol Sci (2004) 0.87
The ability of the aryl hydrocarbon receptor to regulate ovarian follicle growth and estradiol biosynthesis in mice depends on stage of sexual maturity. Biol Reprod (2010) 0.87
Effect of methoxychlor and estradiol on cytochrome p450 enzymes in the mouse ovarian surface epithelium. Toxicol Sci (2005) 0.86
Bisphenol A inhibits cultured mouse ovarian follicle growth partially via the aryl hydrocarbon receptor signaling pathway. Reprod Toxicol (2013) 0.86
The association between physical activity and hot flash severity, frequency, and duration in mid-life women. Am J Hum Biol (2008) 0.86
Race and health-related quality of life in midlife women in Baltimore, Maryland. Maturitas (2009) 0.85
Methoxychlor induces atresia of antral follicles in ERalpha-overexpressing mice. Toxicol Sci (2006) 0.85
Endogenous hormones, participant characteristics, and symptoms among midlife women. Maturitas (2008) 0.85
Renewed debate over postnatal oogenesis in the mammalian ovary. Bioessays (2004) 0.85
Bcl-x is not required for maintenance of follicles and corpus luteum in the postnatal mouse ovary. Biol Reprod (2002) 0.85
Methoxychlor reduces estradiol levels by altering steroidogenesis and metabolism in mouse antral follicles in vitro. Toxicol Appl Pharmacol (2011) 0.85
Methoxychlor-induced ovarian follicle toxicity in mice: dose and exposure duration-dependent effects. Birth Defects Res B Dev Reprod Toxicol (2012) 0.85
Bisphenol A down-regulates rate-limiting Cyp11a1 to acutely inhibit steroidogenesis in cultured mouse antral follicles. Toxicol Appl Pharmacol (2013) 0.84
Methoxychlor inhibits growth of antral follicles by altering cell cycle regulators. Toxicol Appl Pharmacol (2009) 0.83
Dopamine agonist therapy for hyperprolactinemia. Clin Obstet Gynecol (2003) 0.83
Factors that may influence the experience of hot flushes by healthy middle-aged women. J Womens Health (Larchmt) (2010) 0.83
Cosmetologists and reproductive outcomes. Obstet Gynecol (2009) 0.83
Medication use, tamoxifen (TAM), and TAM metabolite concentrations in women with breast cancer. Cancer Lett (2004) 0.83
Reproductive history and hot flashes in perimenopausal women. J Womens Health (Larchmt) (2012) 0.82
Genistein exposure during the early postnatal period favors the development of obesity in female, but not male rats. Toxicol Sci (2013) 0.81